Clinical Trials Sponsored by Arlene Schmid

Total 449 results

Vitaccess Ltd
argenx

Recruiting

The Impact of Myasthenia Gravis in the Real World

Myasthenia Gravis

United Kingdom
argenx
Quintiles, Inc.

Completed

A Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of ARGX-113 in Patients With ITP

Primary Immune Thrombocytopenia

Austria, Belgium, France, Germany, Spain, Czechia, Hungary, Poland, Ukraine, United Kingdom
Clene Nanomedicine
Clene Australia Pty Ltd

Terminated

Nanocrystalline Gold to Treat Remyelination Failure in Chronic Optic Neuropathy In Multiple Sclerosis (VISIONARY-MS)

Relapsing Remitting Multiple Sclerosis | Optic Neuropathy | Optic; Neuritis, With Demyelination

United States, Canada, Australia
Clene Nanomedicine
Clene Australia Pty Ltd

Completed

Therapeutic Nanocatalysis to Slow Disease Progression of Amyotrophic Lateral Sclerosis (ALS) (RESCUE-ALS)

Amyotrophic Lateral Sclerosis

Australia
Arena Pharmaceuticals

Completed

Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis (ELEVATE UC 12)

Ulcerative Colitis

United States, Spain, Israel, Netherlands, Australia, Korea, Republic of, Czechia, Italy, Russian Federation, Croatia, Portugal, Serbia, Belarus, Canada, Georgia, Hungary, Ukraine, Germany, Poland, Belgium, Turkey, Japan, Thailand, India and more
Arena Pharmaceuticals

Completed

Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis (ELEVATE UC 52)

Ulcerative Colitis

Israel, Spain, United States, Australia, Denmark, Korea, Republic of, Czechia, Russian Federation, Croatia, Portugal, Serbia, Taiwan, Canada, Bulgaria, Belarus, Georgia, Hungary, Italy, Latvia, Netherlands, Ukraine, Germany, Poland, B... and more
Arena Pharmaceuticals

Completed

A Study to Assess the Safety and Efficacy of Etrasimod in Subjects With Moderate-to-Severe Atopic Dermatitis (ADVISE)

Atopic Dermatitis

United States, Australia, Canada
Arena Pharmaceuticals

Terminated

Safety, Tolerability, and Efficacy of Etrasimod (APD334) in Participants With Primary Biliary Cholangitis

Primary Biliary Cholangitis

United States, Australia, New Zealand
Arena Pharmaceuticals

Completed

Tolerability, Pharmacokinetics, and Efficacy of APD371 in Participants With Crohn's Disease Experiencing Abdominal Pain

Abdominal Pain | Crohn's Disease

United States
Arena Pharmaceuticals

Terminated

Efficacy and Safety of Etrasimod (APD334) in Inflammatory Bowel Disease Patients With Active Skin Extra-intestinal Manifestations

Inflammatory Bowel Diseases | Skin Extra-intestinal Manifestations

Belgium, Germany, Serbia
Arena Pharmaceuticals

Completed

Single-Dose Safety Study of APD791 in Healthy Volunteers

Healthy

United States
Clene Nanomedicine

Available

Intermediate Expanded Access Protocol (EAP) CNMAu8.EAP02

Amyotrophic Lateral Sclerosis

United States
Clene Nanomedicine

Active, not recruiting

An Open-Label Extension for the Phase 2 Study in Early Symptomatic Amyotrophic Lateral Sclerosis Patients on Stable Background Therapy to Assess Bioenergetic Catalysis With CNM-Au8 to Slow Disease Progression in ALS

Amyotrophic Lateral Sclerosis

Australia
Aalen University

Completed

Comparison of Four Methods for Entering the Gap Position of Landolt Cs (LC_Entry)

Validation Study | Quality Control

Germany
Arena Pharmaceuticals

Terminated

Olorinab in Irritable Bowel Syndrome With Predominant Constipation (IBS-C) and Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D) (CAPTIVATE)

Irritable Bowel Syndrome

United States
Arena Pharmaceuticals

Completed

A Multiple-Dose Study to Assess the Safety, Tolerability, and Steady State Pharmacokinetics of APD791 in Healthy Volunteers

Healthy

United States
Arena Pharmaceuticals

Terminated

Efficacy and Safety of APD334 in Patients With Pyoderma Gangrenosum

Pyoderma Gangrenosum

Australia, New Zealand
Arena Pharmaceuticals

Completed

Safety and Efficacy of Etrasimod (APD334) in Patients With Ulcerative Colitis

Ulcerative Colitis

United States, Australia, Austria, Belgium, Bulgaria, Canada, Czechia, France, Germany, Hungary, Israel, Korea, Republic of, Latvia, Lithuania, New Zealand, Poland, Romania, Russian Federation, Spain, Ukraine, United Kingdom
Clene Nanomedicine

Completed

A Phase I SAD and MAD Clinical Trial of CNM-Au8 in Healthy Male and Female Volunteers

Healthy Volunteers - Male and Female

Netherlands
Arena Pharmaceuticals

Completed

A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation

Smoking Cessation

United States
Arena Pharmaceuticals

Completed

Single-dose Safety Study of APD916 in Healthy Volunteers

Narcolepsy With or Without Cataplexy

United States
Arena Pharmaceuticals

Completed

Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis

Ulcerative Colitis

United States, Australia, Austria, Belgium, Bulgaria, Canada, Czechia, France, Germany, Hungary, Israel, Korea, Republic of, Latvia, Lithuania, New Zealand, Poland, Romania, Russian Federation, Spain, Ukraine, United Kingdom
Arena Pharmaceuticals

Terminated

Effect of Olorinab on Gastrointestinal Transit in Patients With Irritable Bowel Syndrome

Irritable Bowel Syndrome

United States
Arena Pharmaceuticals

Completed

Subjective Study to Assess the Efficacy of APD125 in Patients With Sleep Maintenance Insomnia

Primary Insomnia

United States
Arete Therapeutics

Completed

Evaluation of Soluble Epoxide Hydrolase (s-EH) Inhibitor in Patients With Mild to Moderate Hypertension and Impaired Glucose Tolerance

Hypertension | Impaired Glucose Tolerance

United States
Arena Pharmaceuticals

Completed

Safety and Efficacy Study of APD125 in Patient With Insomnia

Insomnia

United States
Ursula Schmidt-Erfurth, M.D.

Completed

Bevacizumab Versus Ranibizumab for Diabetic Retinopathy

Diabetic Retinopathy | Diabetic Macular Edema | Proliferative Diabetic Retinopathy

Austria
Prof. Dr. Alice Schmidt

Unknown

Hepatitis C in Renal Transplant Recipients

Renal Transplantation | Chronic Hepatitis C-virus Infection

Austria
University of California, San Diego
Michael and Arlene Rosen Foundation

Completed

Evaluating Body Acceptance Programs for Young Men

Body Image Disturbance | Eating Disorders | Eating Disorder Symptom | Dysmorphia

United States
Level 42 AI, Inc.
Johns Hopkins University; Schmidt Futures

Completed

imPulse™ Una Full-spectrum, Over Clothing E-stethoscope

Corona Virus Infection | Coronavirus

United States
Darlene A. Lobel, MD

Completed

Music-listening During Deep Brain Stimulation to Relieve Anxiety

Movement Disorders | Deep Brain Stimulation

United States
argenx
Iqvia Pty Ltd

Completed

Efficacy and Safety Study of Efgartigimod in Adults With Post-COVID-19 POTS (POTS)

Postural Orthostatic Tachycardia Syndrome

United States
argenx
Iqvia Pty Ltd

Active, not recruiting

Open-Label Extension Study to Evaluate the Safety of Efgartigimod in Adult Patients With Primary Sjögren's Syndrome (Rho plus)

Primary Sjögren's Syndrome

Belgium, Hungary, Poland
argenx
Iqvia Pty Ltd

Completed

A Study of the Safety and Effectiveness of Efgartigimod in Patients With Primary Sjögren's Syndrome (pSS) (rho)

Primary Sjögren's Syndrome

Belgium, Poland, Hungary, Netherlands
argenx
Iqvia Pty Ltd

Active, not recruiting

Open Label Extension of Efgartigimod in Adults With Post-COVID-19 POTS (POTS)

Post-COVID Postural Orthostatic Tachycardia Syndrome Postural Orthostatic Tachycardia Syndrome

United States
André Schmidt

Completed

D-serine Supplementation for Depression

Major Depressive Disorder

Switzerland
Achim Schmitz

Completed

Sedation MRI - Propofol Versus Propofol-Ketamin in Children

Sedation

Switzerland
Heinrich Schima

Terminated

Physiological Control for Mechanical Circulatory Devices (REGALVAD)

Heart Failure

Austria
Marlene A Hansen, Stud.med

Completed

Conventional Verses Ultrasound Guided Arteria Cannulation, With and Without Local Anesthesia

Heart Disease

Denmark
Achim Schmitz

Completed

Gastric pH in Intubated Children

Preoperative Fasting

Switzerland
Université de Reims Champagne-Ardenne

Not yet recruiting

Use of the Free Male Condom Scheme in Young Adults Aged 18 to 25 (Préservatif)

Comdom

France
Université de Reims Champagne-Ardenne

Not yet recruiting

Prevalence of Falls and Associated Factors in Haemodialysis Patients (Chute-Hemo)

Haemodialysis Patients

France
Université de Reims Champagne-Ardenne

Not yet recruiting

Subjects Perceived as Embarrassing During a Consultation in General Medical Practice (Gene-MG)

General Practice

France
Université de Reims Champagne-Ardenne

Not yet recruiting

Gynaecological Follow-up of Women With Down Syndrom Aged 18 to 30 in France (Gyn-T21)

Down Syndrome

France
Université de Reims Champagne-Ardenne

Not yet recruiting

Knowledge of Pregnant Women Concerning Pertussis, Vaccination Against Pertussis and Cocooning Strategy (Coqueluche-Vac)

Pertussis
Université de Reims Champagne-Ardenne

Recruiting

Knowledge of Young Adults About Genital Herpes (HerpesG)

Genital Herpes

France
Université de Reims Champagne-Ardenne

Not yet recruiting

Interest of a Short Early Psychological Care in Women With Miscarriage (MisTher)

Miscarriage
Université de Reims Champagne-Ardenne

Recruiting

Work-related Stress Among Recently Graduated Midwives Practicing in the Delivery Room (Stress-SF)

Recently Graduated Midwives Practicing in the Delivery Room

France
Université de Reims Champagne-Ardenne

Recruiting

Factors Associated With Gynecological Consultation by General Practitioner (Gyn-MG)

Adult Daughters

France
Université de Reims Champagne-Ardenne

Not yet recruiting

Perception of Blood Sugar Variations During Physical Activity in Healthy Subjects and Type 1 Diabetes Patients (GLYSPORT)

Type 1 Diabetes

Clinical Trials Sponsored by Arlene Schmid

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sri Lanka

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations